Effect of Tartary Buckwheat Tea Combined with Dietary Intervention on Post-Stroke Fatigue in Patients with Ischemic Stroke: A Single-Center, Open-Label Randomized Controlled Trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2600123463

Enrollment

Unknown

Registered

2026-04-27

Start date

2026-05-01

Completion date

Unknown

Last updated

2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

Intervention Group:the dietary guidance based on Dietary Guidelines for Stroke Patients (2017) and tartary buckwheat tea

Control group:the dietary guidance based on Dietary Guidelines for Stroke Patients (2017)

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for ischemic stroke as established in the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018" 2. Meets the diagnostic criteria for post-stroke fatigue established by DE Groot et al. 3. Total score on the Chinese version of the Fatigue Severity Scale (FSS) >= 36 points 4. Post-stroke neurological function assessed as mild to moderate stroke: NIHSS score = 2 weeks 6. Age >= 18 years 7. Patients and their families understand and actively cooperate with this study; patients can ensure full compliance during the trial and follow-up

Exclusion criteria

Exclusion criteria: 1. Individuals with pre-stroke fatigue symptoms or with other neurological diseases that can cause fatigue, such as Parkinson's disease, epilepsy, hypokalemia, hyponatremia, hypoglycemia, anxiety (HAMA score = Grade 3). 4. Patients with liver or kidney dysfunction. 5. Individuals planning pregnancy, refusing contraception, or who are pregnant or breastfeeding. 6. Individuals with language expression disorders or who cannot understand the assessment scales. 7. Extreme BMI values: 50 kg/m². 8. Individuals whose blood glucose is still not well controlled despite standardized use of hypoglycemic drugs or insulin. 9. Participants in other clinical trials or receiving other dietary therapies. 10. Individuals currently taking other Chinese herbal medicines. 11. Individuals with a history of severe mental illness. 12. Individuals with plans to travel abroad within the past two months.

Design outcomes

Primary

Measure	Time frame
Fatigue Severity Scale (FSS);	—

Secondary

Measure	Time frame
Waist-to-hip ratio (WHR);Energy domain of the Stroke-Specific Quality of Life Scale (SS-QOL);Multidimensional Fatigue Inventory (MFI-20);Waist-to-height ratio (WHtR);BMI;	—

Countries

China

Contacts

Public ContactQian Zhang

Shanxi Bethune Hospital

zhangqian@d.sxmu.edu.cn+86 138 3517 6091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026